MENU

Getting Started

NEW YORK

+1 646-679-4321

get directions

LONDON

+44 203-289-5319

get directions

OUR SERVICES

Analyst & Institutional
Engagement
Brand Visibility &
Market Presence
Environmental, Social &
Governance (ESG) Disclosures
Investor Engagement
& Enrichment
AI & Digital Transformation

NEW YORK

+1 646-679-4321

get directions

LONDON

+44 203-289-5319

get directions

Co-Diagnostics hopes to
submit rapid COVID at-home
test for FDA approval this summer

bda-blogs

Co-Diagnostics CEO Dwight Egan on the importance of building a coronavirus testing protocol into the ‘workflow of life’ from now on.

Related publications you might be interested in

bda-blogs
‘We believe robust testing will be required in order to normalize’ post-pandemic: Co-Diagnostics CEO
Read More
bda-blogs
BetterLife CEO Highlights Crucial Difference Between the Company’s Interferon Alpha 2b and Other Treatements
Read More
Back to
Articles

06CONTACT

Ready for the next phase in your capital markets journey?

Contact Us
LOCATION 1

NEW YORK

375, 5th Avenue, Suite 1402,
New York, NY, 10016

+1 646-679-4321

LOCATION 2

LONDON

Level 33, 25 Canada Square,
Canary Wharf, London E14 5LB,

+44 203-289-5319

E-Mail

Services@bda-ir.com